Full text is available at the source.
Abstract
Reports suggest that rash, urticaria, and alopecia may occur with greater frequency in children on injectable GLP-1 receptor agonists compared to adults.
- Dermatologic adverse events associated with GLP-1 receptor agonists in children are less documented than in adults.
- Facial lipodystrophy is more commonly reported in adults using GLP-1 receptor agonists.
- Current evidence indicates potential differences in the types of dermatologic adverse events experienced by children and adults.
- The data on pediatric dermatologic adverse events remain limited, highlighting the need for further research.
Simplified